Clomicalm

1 in 5 dogs are estimated to be affected by separation anxiety1 and following the growth of dog ownership during lockdown, and the imminent re-opening of workplaces, it is anticipated that veterinary teams will be facing an increase in separation anxiety cases being presented in practice.

Dogs receiving Clomicalm have been shown to have a decreased level of fear and anxiety and an increased receptivity to behavioural modification2. The meat-flavoured tablets are presented in ‘easy to dispense’ 30 tablet packs of 5mg, 20mg & 80mg tablets, and are divisible in two for ease of administration and accurate dosing.

<sub>References 
<sup>1. Salonen, M., Sulkama, S., Mikkola, S., Puurunen, J., Hakanen, E., Tiira, K., Araujo, C. and Lohi, H., 2020. Prevalence, comorbidity, and breed differences in canine anxiety in 13,700 Finnish pet dogs. Scientific Reports, 10(1).
2. US-European Clinical Trial. Internal Data (CLM1998).</sup></sub>

Features & Benefits: 

• Clomipramine hydrochloride available in three presentations: 5mg, 20mg & 80mg
• Inhibits the neuronal reuptake of serotonin and norepinephrine
• Clomipramine is a broad-spectrum tricyclic antidepressant and does not act as a sedative
• Meat-flavoured tablets to aid acceptance and owner compliance
• Tablets are divisible in two for ease of administration and accurate dosing
• Presented in easy to dispense 30 tablet packs

Use medicines responsibly. www.noah.co.uk/responsible.
Further information is available on the SPC or on request from Virbac Ltd.